UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 For the quarter ended: December 29, 2018 Commission File Number: 001-14041 HAEMONETICS CORPORATION (Exact name of registrant as specified in its charter) Massachusetts (State or other jurisdiction of incorporation or organization) 04-2882273 (I.R.S. Employer Identification No.) FORM 10-Q Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 400 Wood Road, Braintree, MA 02184 Large accelerated filer þ Ac ...

Haemonetics Corporation (NYSE:HAE) Q3 2019 Results Conference Call February 5, 2019 8:00 AM ET Company Participants Olga Vlasova - IR Chris Simon - CEO Bill Burke - CFO David Wilson - President, Global Plasma Conference Call Participants David Lewis - Morgan Stanley Anthony Petrone - Jefferies David Turkaly - JMP Securities Andrew Brackmann - William Blair Jim Sidoti - Sidoti and Company Operator Good day, ladies and gentlemen, and welcome to the Q3 2019 Haemonetics Corporation Earnings Conference Call. At ...